FAFFX | REGTX | FAFFX / REGTX | |
Total Expense Ratio | 0.92 | 0.41 | 224% |
Annual Report Gross Expense Ratio | 0.92 | 0.41 | 224% |
Fund Existence | 22 years | 19 years | - |
Gain YTD | 11.520 | 15.690 | 73% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.89B | 50B | 6% |
Annual Yield % from dividends | 1.13 | 1.35 | 84% |
Returns for 1 year | 10.09 | 14.60 | 69% |
Returns for 3 years | 50.22 | 46.67 | 108% |
Returns for 5 years | 30.80 | 44.15 | 70% |
Returns for 10 years | 46.62 | 96.39 | 48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLOW | 29.87 | 0.43 | +1.46% |
VictoryShares WestEnd Global Equity ETF | |||
QTEC | 219.92 | 2.00 | +0.92% |
First Trust NASDAQ-100-Tech Sector ETF | |||
LEO | 6.20 | 0.02 | +0.32% |
BNY Mellon Strategic Municipals | |||
BBC | 24.00 | -0.12 | -0.50% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
BMVP | 48.79 | -0.32 | -0.65% |
Invesco Bloomberg MVP Multi-factor ETF |